Related Experiment Video
Updated: Jun 23, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
What's in an intron? CCN1 mRNA splicing in cancer
1CIHR Group in Skeletal Development and Remodeling, Division of Oral Biology and Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, Dental Sciences Building, London, ON, Canada, N6A 5C1, Andrew.leask@schulich.uwo.ca.
Abstract:
The CCN family of matricellular signaling regulators shares a common domain structure. Variants of individual CCN proteins exist, which contain different combinations of these domains. Although mRNA splicing is likely to play a key role on CCN biology, this hypothesis has not been thoroughly tested. In a recent report, Hirschfeld and colleagues (Cancer Res 69:2082-90, 2009), show that CCN1 (cyr61) mRNA is normally present in a form in which intron 3 is retained. In cancers, or upon hypoxia, intron 3 is removed resulting in the appearance of CCN1 protein. The significance of this paper is discussed.
Insights
CCN1 (cyr61) mRNA splicing regulates protein expression. Intron 3 retention is normal, but its removal in cancers or hypoxia generates CCN1 protein, impacting cell signaling.
Area of Science:
- Cellular biology
- Molecular biology
- Biochemistry
Background:
- The CCN family comprises matricellular signaling regulators with conserved domain structures.
- CCN protein variants arise from differing domain combinations.
- The role of mRNA splicing in CCN biology remains largely uninvestigated.
Purpose of the Study:
- To investigate the role of mRNA splicing in CCN1 (cyr61) biology.
- To determine how CCN1 protein variants are generated.
- To explore the significance of CCN1 splicing in disease contexts.
Main Methods:
- Analysis of CCN1 mRNA splicing patterns.
- Investigation of CCN1 expression under normal, cancerous, and hypoxic conditions.
Main Results:
- CCN1 mRNA normally retains intron 3.
- Intron 3 removal occurs in cancer cells and under hypoxic conditions.
- Intron 3 removal leads to the production of CCN1 protein.
Conclusions:
- mRNA splicing, specifically intron 3 retention/removal, is a key mechanism regulating CCN1 protein expression.
- Altered CCN1 splicing is associated with cancer and hypoxia.
- This splicing mechanism offers potential insights into CCN1's role in disease pathogenesis.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
